Drug search by name

Dexbrompheniramine and Pseudoephedrine Tablets and GI narrowing

Result of checking the interaction of drug Dexbrompheniramine and Pseudoephedrine Tablets and disease GI narrowing for safety when used together.

Check result:

Dexbrompheniramine and Pseudoephedrine Tablets <> GI narrowing

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The extended-release formulation of pseudoephedrine (Sudafed 24 Hour) contains a non-deformable material. There have been rare reports of obstructive symptoms in patients with known strictures following the ingestion of similar sustained-release products. Therapy with the extended-release formulation of pseudoephedrine should be administered cautiously in patients with preexisting severe gastrointestinal narrowing or obstruction, whether pathologic or iatrogenic.

References:

"Product Information. Sudafed (pseudoephedrine)." Glaxo Wellcome, Research Triangle Park, NC.

Dexbrompheniramine and Pseudoephedrine Tablets

Generic Name: dexbrompheniramine / pseudoephedrine

Brand Name: Conex, Drixoral Cold and Allergy, Drexophed SR, Desihist SA, Duomine, Dexophed, Disobrom, Disophrol, Drixoral, 12 Hour Cold, Dexaphen SA, Dixaphedrine, Drixomed, Pharmadrine, Ala Hist PE, Ala-Hist PE, Drixoral Sinus

Synonyms: Dexbrompheniramine and pseudoephedrine, Brompheniramine and Pseudoephedrine Drops

What is Dexbrompheniramine and Pseudoephedrine Tablets?